
### [MONDO:0000732](http://purl.obolibrary.org/obo/MONDO_0000732)
**Label:** combined oxidative phosphorylation deficiency

**Subclasses:** [MONDO:0014684](http://purl.obolibrary.org/obo/MONDO_0014684) (combined oxidative phosphorylation defect type 26), [MONDO:0013971](http://purl.obolibrary.org/obo/MONDO_0013971) (leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome), [MONDO:0014269](http://purl.obolibrary.org/obo/MONDO_0014269) (combined oxidative phosphorylation deficiency 19), [MONDO:0013570](http://purl.obolibrary.org/obo/MONDO_0013570) (combined oxidative phosphorylation defect type 8), [MONDO:0014781](http://purl.obolibrary.org/obo/MONDO_0014781) (combined oxidative phosphorylation deficiency 29; COXPD29), [MONDO:0014261](http://purl.obolibrary.org/obo/MONDO_0014261) (growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome), [MONDO:0014162](http://purl.obolibrary.org/obo/MONDO_0014162) (infantile hypertrophic cardiomyopathy due to MRPL44 deficiency), [MONDO:0013977](http://purl.obolibrary.org/obo/MONDO_0013977) (combined oxidative phosphorylation defect type 13), [MONDO:0014728](http://purl.obolibrary.org/obo/MONDO_0014728) (combined oxidative phosphorylation defect type 27), [MONDO:0014547](http://purl.obolibrary.org/obo/MONDO_0014547) (combined oxidative phosphorylation defect type 24), [MONDO:0014525](http://purl.obolibrary.org/obo/MONDO_0014525) (combined oxidative phosphorylation defect type 23), [MONDO:0013811](http://purl.obolibrary.org/obo/MONDO_0013811) (combined oxidative phosphorylation defect type 9), [MONDO:0014398](http://purl.obolibrary.org/obo/MONDO_0014398) (combined oxidative phosphorylation defect type 21), [MONDO:0014775](http://purl.obolibrary.org/obo/MONDO_0014775) (neonatal severe cardiopulmonary failure due to mitochondrial methylation defect), [MONDO:0014471](http://purl.obolibrary.org/obo/MONDO_0014471) (isolated ATP synthase deficiency), [MONDO:0014397](http://purl.obolibrary.org/obo/MONDO_0014397) (combined oxidative phosphorylation defect type 20), [MONDO:0014190](http://purl.obolibrary.org/obo/MONDO_0014190) (combined oxidative phosphorylation defect type 17), [MONDO:0012191](http://purl.obolibrary.org/obo/MONDO_0012191) (Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1), [MONDO:0014091](http://purl.obolibrary.org/obo/MONDO_0014091) (mitochondrial complex v (ATP synthase) deficiency nuclear type 4), [MONDO:0012718](http://purl.obolibrary.org/obo/MONDO_0012718) (hypotonia with lactic acidemia and hyperammonemia), [MONDO:0013306](http://purl.obolibrary.org/obo/MONDO_0013306) (combined oxidative phosphorylation defect type 7), [MONDO:0012534](http://purl.obolibrary.org/obo/MONDO_0012534) (combined oxidative phosphorylation defect type 4), [MONDO:0012512](http://purl.obolibrary.org/obo/MONDO_0012512) (fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3), [MONDO:0013969](http://purl.obolibrary.org/obo/MONDO_0013969) (combined oxidative phosphorylation defect type 11), [MONDO:0011421](http://purl.obolibrary.org/obo/MONDO_0011421) (mitochondrial complex v (ATP synthase) deficiency, nuclear type 1), [MONDO:0012510](http://purl.obolibrary.org/obo/MONDO_0012510) (combined oxidative phosphorylation defect type 2), [MONDO:0010437](http://purl.obolibrary.org/obo/MONDO_0010437) (severe X-linked mitochondrial encephalomyopathy), [MONDO:0014976](http://purl.obolibrary.org/obo/MONDO_0014976) (lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome), [MONDO:0013986](http://purl.obolibrary.org/obo/MONDO_0013986) (combined oxidative phosphorylation defect type 14), [MONDO:0013865](http://purl.obolibrary.org/obo/MONDO_0013865) (mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency), [MONDO:0014636](http://purl.obolibrary.org/obo/MONDO_0014636) (combined oxidative phosphorylation defect type 25), [MONDO:0014856](http://purl.obolibrary.org/obo/MONDO_0014856) (combined oxidative phosphorylation defect type 30), [MONDO:0013987](http://purl.obolibrary.org/obo/MONDO_0013987) (combined oxidative phosphorylation defect type 15), [MONDO:0013547](http://purl.obolibrary.org/obo/MONDO_0013547) (mitochondrial complex v (ATP synthase) deficiency nuclear type 3), 

**Corr. equiv. classes:** [OMIM:611719](http://purl.obolibrary.org/obo/OMIM_611719), [Orphanet:319504](http://www.orpha.net/ORDO/Orphanet_319504), [Orphanet:314051](http://www.orpha.net/ORDO/Orphanet_314051), [Orphanet:319509](http://www.orpha.net/ORDO/Orphanet_319509), [OMIM:615440](http://purl.obolibrary.org/obo/OMIM_615440), [Orphanet:478049](http://www.orpha.net/ORDO/Orphanet_478049), [Orphanet:324535](http://www.orpha.net/ORDO/Orphanet_324535), [Orphanet:137681](http://www.orpha.net/ORDO/Orphanet_137681), [OMIM:616974](http://purl.obolibrary.org/obo/OMIM_616974), [Orphanet:478042](http://www.orpha.net/ORDO/Orphanet_478042), [OMIM:616811](http://purl.obolibrary.org/obo/OMIM_616811), [OMIM:617228](http://purl.obolibrary.org/obo/OMIM_617228), [Orphanet:466784](http://www.orpha.net/ORDO/Orphanet_466784), [OMIM:610678](http://purl.obolibrary.org/obo/OMIM_610678), [OMIM:616539](http://purl.obolibrary.org/obo/OMIM_616539), [Orphanet:137908](http://www.orpha.net/ORDO/Orphanet_137908), [Orphanet:254930](http://www.orpha.net/ORDO/Orphanet_254930), [Orphanet:369913](http://www.orpha.net/ORDO/Orphanet_369913), [Orphanet:352563](http://www.orpha.net/ORDO/Orphanet_352563), [OMIM:609060](http://purl.obolibrary.org/obo/OMIM_609060), [OMIM:615578](http://purl.obolibrary.org/obo/OMIM_615578), [Orphanet:420733](http://www.orpha.net/ORDO/Orphanet_420733), [OMIM:613559](http://purl.obolibrary.org/obo/OMIM_613559), [OMIM:614924](http://purl.obolibrary.org/obo/OMIM_614924), [OMIM:614922](http://purl.obolibrary.org/obo/OMIM_614922), [Orphanet:447954](http://www.orpha.net/ORDO/Orphanet_447954), [Orphanet:319524](http://www.orpha.net/ORDO/Orphanet_319524), [Orphanet:254920](http://www.orpha.net/ORDO/Orphanet_254920), [Orphanet:477774](http://www.orpha.net/ORDO/Orphanet_477774), [OMIM:616794](http://purl.obolibrary.org/obo/OMIM_616794), [OMIM:616672](http://purl.obolibrary.org/obo/OMIM_616672), [OMIM:616430](http://purl.obolibrary.org/obo/OMIM_616430), [OMIM:616198](http://purl.obolibrary.org/obo/OMIM_616198), [Orphanet:254925](http://www.orpha.net/ORDO/Orphanet_254925), [OMIM:614096](http://purl.obolibrary.org/obo/OMIM_614096), [OMIM:614053](http://purl.obolibrary.org/obo/OMIM_614053), [Orphanet:420728](http://www.orpha.net/ORDO/Orphanet_420728), [OMIM:300816](http://purl.obolibrary.org/obo/OMIM_300816), [OMIM:615228](http://purl.obolibrary.org/obo/OMIM_615228), [OMIM:614932](http://purl.obolibrary.org/obo/OMIM_614932), [Orphanet:314637](http://www.orpha.net/ORDO/Orphanet_314637), [OMIM:616239](http://purl.obolibrary.org/obo/OMIM_616239), [OMIM:610498](http://purl.obolibrary.org/obo/OMIM_610498), [Orphanet:168566](http://www.orpha.net/ORDO/Orphanet_168566), [Orphanet:444458](http://www.orpha.net/ORDO/Orphanet_444458), [Orphanet:391348](http://www.orpha.net/ORDO/Orphanet_391348), [Orphanet:444013](http://www.orpha.net/ORDO/Orphanet_444013), [Orphanet:319514](http://www.orpha.net/ORDO/Orphanet_319514), [Orphanet:238329](http://www.orpha.net/ORDO/Orphanet_238329), [Orphanet:319519](http://www.orpha.net/ORDO/Orphanet_319519), [Orphanet:477684](http://www.orpha.net/ORDO/Orphanet_477684), [OMIM:614582](http://purl.obolibrary.org/obo/OMIM_614582), [OMIM:616045](http://purl.obolibrary.org/obo/OMIM_616045), [OMIM:615595](http://purl.obolibrary.org/obo/OMIM_615595), [OMIM:615395](http://purl.obolibrary.org/obo/OMIM_615395), [Orphanet:254913](http://www.orpha.net/ORDO/Orphanet_254913), [OMIM:614946](http://purl.obolibrary.org/obo/OMIM_614946), [OMIM:604273](http://purl.obolibrary.org/obo/OMIM_604273), [OMIM:614947](http://purl.obolibrary.org/obo/OMIM_614947), [OMIM:614702](http://purl.obolibrary.org/obo/OMIM_614702), [OMIM:615918](http://purl.obolibrary.org/obo/OMIM_615918), [OMIM:610505](http://purl.obolibrary.org/obo/OMIM_610505), [OMIM:615917](http://purl.obolibrary.org/obo/OMIM_615917), 

**Class expressions from DL-Learner:**

- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 48.05%
- [HP:0001252](http://purl.obolibrary.org/obo/HP_0001252) (Muscular hypotonia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 48.05%
- [HP:0001252](http://purl.obolibrary.org/obo/HP_0001252) (Muscular hypotonia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 47.29%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 46.50%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 46.09%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 45.93%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 44.91%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 44.91%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 44.72%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 44.57%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 44.36%
- [HP:0001290](http://purl.obolibrary.org/obo/HP_0001290) (Generalized hypotonia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 44.22%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 43.89%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 42.65%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 42.14%


